Raia Drogasil S.A. (BOVESPA:RADL3) entered into a Share Purchase Agreement to acquire CUCO Health app from Dr. CUCO on August 10, 2021. The transaction has been approved by the Raia Drogasil Board. The deal is further subject to approval from Raia Drogasil S.A. Shareholders and antitrust body Cade.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
25.38 BRL | +1.72% | -0.16% | -13.57% |
Mar. 06 | Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024 | |
Mar. 05 | Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.57% | 8.28B | |
+32.95% | 1.34B | |
+6.76% | 427M | |
+5.93% | 289M | |
+10.56% | 225M | |
-10.09% | 83.49M | |
+20.94% | 59.81M |
- Stock Market
- Equities
- RADL3 Stock
- News Raia Drogasil S.A.
- Raia Drogasil S.A. entered into a Share Purchase Agreement to acquire CUCO Health app from Dr. CUCO.